Litigation Details for Federal Trade Commission v. Advocate Health Care Network (N.D. Ill. 2015)

Federal Trade Commission v. Advocate Health Care Network (N.D. Ill. 2015)

Docket		Date Filed	2015-12-21
Court	District Court, N.D. Illinois	Date Terminated	2017-10-03
Cause	15:0053 Federal Trade Commission Act	Assigned To	Jorge Luis Alonso
Jury Demand	None	Referred To
Patents	7,582,727; 7,598,343
Link to Docket	External link to docket

Details for Federal Trade Commission v. Advocate Health Care Network (N.D. Ill. 2015)

Date Filed	Document No.	Description	Snippet	Link To Document
2015-12-21				External link to document
2015-12-20	77	Appendix of Unreported Cases	that they infringed U.S. Patent Nos. 7,582,727 (the " '727 Patent") and 7,598,343 (the…quot; '343 Patent," and collectively with the '727 Patent, the "patents-in-suit"…1995). When procedural issues in a patent case are not unique to patent law, courts "apply the law …failure to enforce the patents, that led Interlogix to purportedly infringe the patents. Chamberlain Gp. Inc…United States Patent & Trademark Office ("PTO") during prosecution of the patents-in-suit. (	External link to document

FTC v. Advocate Health Care Network, 1:15-cv-11473: Litigation Summary and Antitrust Analysis

Last updated: August 5, 2026

The Federal Trade Commission successfully blocked the proposed merger between Advocate Health Care Network and NorthShore University HealthSystem. The FTC filed suit in December 2015 in the U.S. District Court for the Northern District of Illinois. The district court denied a preliminary injunction, but the U.S. Court of Appeals for the Seventh Circuit reversed that decision and ordered the district court to enjoin the transaction. The parties abandoned the merger in December 2016.

The case is a leading hospital-merger decision on geographic market definition, insurer bargaining power, hospital substitutability, and the evidentiary standard for preliminary injunctions under Section 7 of the Clayton Act.

What was FTC v. Advocate Health Care Network about?

The FTC challenged the proposed combination of Advocate Health Care Network and NorthShore University HealthSystem, two major hospital systems operating in the Chicago metropolitan area.

Advocate was the largest hospital system in Illinois. NorthShore operated hospitals and outpatient facilities in Chicago’s northern suburbs. The proposed transaction would have combined systems with substantial overlap in the North Shore area and would have created a large provider with increased leverage in negotiations with commercial health insurers.

The FTC alleged that the transaction would substantially lessen competition for inpatient general acute-care hospital services sold to commercial insurers. The agency focused on local hospital markets in which Advocate and NorthShore were close competitors.

Case identification

Item	Detail
Case	FTC v. Advocate Health Care Network
District court	U.S. District Court for the Northern District of Illinois
Civil action number	1:15-cv-11473
Appellate citation	FTC v. Advocate Health Care Network, 841 F.3d 460 (7th Cir. 2016)
Statute	Section 7 of the Clayton Act, 15 U.S.C. § 18
Plaintiff	Federal Trade Commission
Defendants	Advocate Health Care Network and NorthShore University HealthSystem
Complaint filed	December 18, 2015
District court result	Preliminary injunction denied
Seventh Circuit result	Reversed and remanded
Transaction result	Parties abandoned the merger in December 2016

Which companies were involved in the proposed hospital merger?

Advocate Health Care Network and NorthShore University HealthSystem were the transaction parties.

Advocate Health Care Network

Advocate operated multiple hospitals across the Chicago region and had a substantial commercial-insurance business. Its facilities included hospitals serving the northern and northwestern suburbs of Chicago.

NorthShore University HealthSystem

NorthShore operated hospitals in Evanston, Glenview, Highland Park, and Skokie, Illinois, and was a major provider in the northern Chicago suburban market.

Proposed transaction

The parties announced a combination that would have created an integrated health system with:

• Approximately 16 hospitals;
• More than 4,000 affiliated physicians;
• More than $3 billion in annual revenue, according to transaction-era public descriptions;
• A particularly strong presence in the Chicago North Shore region.

The FTC treated the transaction as a horizontal merger because both systems competed for the same commercially insured hospital patients and insurer contracts.

What markets did the FTC define in Advocate?

The FTC defined relevant product markets around inpatient general acute-care hospital services provided to commercial health plans and their members. The agency did not treat every hospital in the Chicago metropolitan area as an effective substitute.

The agency’s geographic analysis relied on local patient flows, travel times, hospital characteristics, insurer contracting evidence, and the practical limits on patients’ willingness to travel for hospital care.

The FTC alleged that the transaction threatened competition in four local geographic markets. The relevant competitive question was not whether patients could theoretically travel to any hospital in the region. It was whether insurers and commercially insured patients viewed the merging hospitals as sufficiently close substitutes to constrain prices and contract terms.

Why the geographic market mattered

Hospital mergers frequently turn on geographic market definition. A broad geographic market makes a merger appear less concentrated because more hospitals are included. A narrow market can show that the merging parties account for a large share of hospitals that insurers can realistically use.

The FTC argued that insurers could not readily replace the parties’ hospitals with distant alternatives because:

• Patients often prefer nearby hospitals;
• Emergency and inpatient care is location-sensitive;
• Employers and health plans need adequate local networks;
• Travel time affects hospital selection;
• Hospitals with comparable reputation, specialty capabilities, and physician affiliations are limited;
• Insurers could not credibly threaten to exclude both systems from a commercially viable network.

The Seventh Circuit accepted the FTC’s basic market-definition approach and rejected the argument that the entire Chicago metropolitan area should be treated as the relevant market.

Why did the FTC oppose the Advocate-NorthShore merger?

The FTC alleged that the merger would increase the combined system’s bargaining leverage over commercial insurers and permit higher reimbursement rates.

The agency’s theory was primarily based on unilateral effects. The combined company would no longer need to compete against the other party when negotiating with insurers. That loss of competition could allow the merged system to demand higher prices or more favorable contract terms.

The FTC relied on evidence including:

• High market shares in the affected local markets;
• Significant concentration increases under the Herfindahl-Hirschman Index;
• Patient-flow data;
• Evidence that Advocate and NorthShore were close substitutes;
• Internal documents describing competitive relationships;
• Insurer testimony concerning network negotiations;
• The limited availability of comparable hospitals in the relevant areas.

The FTC did not need to prove that the parties would coordinate with other hospitals. Its theory was that the merged system could act independently because the transaction would eliminate an important competitive constraint.

How did the district court rule?

The district court denied the FTC’s request for a preliminary injunction after an evidentiary hearing.

The court’s decision reflected skepticism about whether the FTC had established a sufficiently narrow relevant geographic market and whether the transaction would probably produce a substantial competitive harm. The defendants argued that insurers could use other hospitals in the broader Chicago region and that competition among health systems would remain strong after the transaction.

The district court also considered the parties’ arguments concerning efficiencies and the ability of insurers to resist price increases. The defendants contended that the transaction would generate operational efficiencies, improve care coordination, expand physician access, and create a stronger integrated system.

The denial allowed the transaction to proceed unless the FTC obtained appellate relief.

Why did the Seventh Circuit reverse the district court?

The Seventh Circuit reversed the district court in an opinion issued in 2016. The appellate court held that the FTC had established a sufficient likelihood of success on the merits to warrant a preliminary injunction.

The decision addressed three central issues.

The FTC’s geographic market was legally plausible

The Seventh Circuit held that the FTC did not need to prove that patients never travel outside the proposed markets. The relevant inquiry was whether hospitals outside the market provided meaningful competitive alternatives to the merging parties.

The court accepted evidence showing that hospital competition is local and that patients, physicians, and insurers do not treat all hospitals in a metropolitan area as interchangeable.

Concentration and competitive overlap supported an inference of harm

The court treated the parties’ market shares and the transaction’s concentration effects as significant evidence. The FTC’s case did not depend on market share alone. It combined concentration data with evidence that the parties were close substitutes and competed directly for insurer contracts.

The appellate court concluded that the FTC had shown a probable reduction in competition, particularly through higher prices paid by commercial insurers.

The defendants did not rebut the FTC’s prima facie case

The Seventh Circuit rejected the proposition that general claims about competition from other hospitals or projected efficiencies were enough to overcome the FTC’s evidence.

The defendants needed to show that the merger’s claimed benefits would prevent the predicted anticompetitive effects. The appellate court found that the evidence did not establish that the alleged efficiencies would offset the loss of competition in the affected markets.

What was the legal standard for the preliminary injunction?

The FTC proceeded under Section 13(b) of the Federal Trade Commission Act, which allows the agency to seek a preliminary injunction while pursuing administrative enforcement.

The court applied the Clayton Act’s Section 7 standard. The FTC needed to show a reasonable probability that the merger may substantially lessen competition. It did not need to prove the full case as if the matter had already reached a final merits trial.

The preliminary-injunction analysis required the court to consider:

1. Whether the FTC was likely to succeed on the merits;
2. Whether the transaction threatened a substantial reduction in competition;
3. Whether the public interest favored blocking the transaction while the case proceeded.

The Seventh Circuit emphasized that the injunction process is designed to preserve competition while the agency completes its administrative review. The court therefore treated the FTC’s burden as less demanding than a final adjudication on all disputed issues.

What was the final outcome of the case?

After the Seventh Circuit ordered the transaction blocked, Advocate and NorthShore abandoned the merger in December 2016. The proposed combination was not completed.

The abandonment eliminated the need for further litigation over consummation of the transaction. The case therefore did not produce a final trial judgment determining all Section 7 merits issues after closing.

The appellate decision nevertheless remains important because it established that:

• Hospital competition can be defined at a local level even in a large metropolitan area;
• Insurer bargaining power does not automatically eliminate hospital market power;
• Patient travel data must be assessed realistically;
• A merger can create anticompetitive risk without coordinated conduct;
• General efficiency claims require evidence tying them to the specific competitive harm alleged.

What did Advocate teach about hospital merger analysis?

The case reinforced several principles relevant to healthcare transactions.

Insurer bargaining power does not automatically defeat an FTC case

Hospital systems often argue that sophisticated insurers can resist price increases. Advocate shows that this argument is fact-specific. A health plan may have substantial bargaining power in the abstract but still face a weak negotiating position if it cannot construct a commercially viable network without the merged hospitals.

Patient choice is not measured only by willingness to travel

A patient may technically be able to travel to another hospital, but that does not make the hospital a strong competitive substitute. The analysis must account for travel time, emergency care, physician relationships, hospital reputation, specialty services, and insurance-network design.

Market shares remain important

The FTC’s case used concentration evidence as part of a broader analysis. High shares and large increases in concentration can establish a prima facie concern, particularly when the merging parties are direct competitors.

Efficiencies must be verifiable and merger-specific

Hospitals frequently claim that mergers will improve coordination, reduce costs, and expand access. Advocate indicates that courts will require evidence showing that claimed efficiencies are verifiable, specific to the merger, and likely to offset the loss of competition.

Did the case involve patents, FDA exclusivity, or Orange Book listings?

No. FTC v. Advocate Health Care Network was a healthcare antitrust case involving a proposed hospital-system merger.

The case did not concern:

• Pharmaceutical patents;
• Biologic patents or biosimilar litigation;
• FDA approval or regulatory exclusivity;
• Orange Book listings;
• Paragraph IV certifications;
• Generic drug entry;
• Formulation or method-of-use patents;
• Manufacturing-process rights.

The relevant intellectual-property issue was therefore none. The litigation focused on hospital services, insurer contracting, market concentration, and merger effects.

What was the commercial significance of the litigation?

The transaction would have combined two major providers in an important regional hospital market. Abandonment preserved Advocate and NorthShore as separate negotiating entities and prevented the parties from realizing the transaction’s proposed scale benefits.

The case also increased antitrust risk for hospital mergers involving:

• Directly competing systems;
• Overlapping hospitals in suburban markets;
• High shares in local inpatient markets;
• Limited comparable alternatives;
• Commercial-insurance reimbursement exposure;
• Physician and hospital affiliations that make substitution difficult.

For healthcare investors and transaction parties, Advocate supports detailed pre-signing analysis of patient flows, insurer networks, hospital substitutability, and local concentration. A broad metropolitan market definition may not withstand scrutiny where actual competition is concentrated in smaller geographic areas.

How strong was the FTC’s case compared with the defendants’ position?

Issue	FTC position	Defendants’ position	Appellate assessment
Product market	Inpatient general acute-care services sold to commercial insurers	Broader hospital-services market	FTC’s framing was sufficiently supported
Geographic market	Local North Shore markets	Broader Chicago metropolitan area	FTC’s local-market approach accepted
Competitive effect	Higher prices and stronger bargaining leverage	Continued insurer discipline and hospital competition	FTC showed probable harm
Patient travel	Patients prefer nearby, comparable hospitals	Patients can use hospitals throughout the region	Theoretical alternatives were not enough
Insurer power	Limited by network needs and lack of substitutes	Insurers can reject excessive prices	Evidence did not defeat FTC’s case
Efficiencies	Not sufficient to offset lost competition	Integration and care-management benefits	Defendants did not establish adequate mitigation
Remedy posture	Preliminary injunction required	Merger should proceed	Seventh Circuit ordered the transaction blocked

Key Takeaways

• The FTC filed the case on December 18, 2015, under Section 7 of the Clayton Act.
• The transaction involved Advocate Health Care Network and NorthShore University HealthSystem.
• The FTC alleged that the merger would reduce competition in local Chicago-area hospital markets.
• The district court denied a preliminary injunction.
• The Seventh Circuit reversed in FTC v. Advocate Health Care Network, 841 F.3d 460 (7th Cir. 2016).
• The appellate court accepted a localized market analysis and found probable anticompetitive effects.
• The parties abandoned the transaction in December 2016.
• The case is a major precedent on hospital-market definition, insurer bargaining power, patient travel, and merger efficiencies.
• No patents, FDA exclusivity, Orange Book listings, or Paragraph IV issues were involved.

FAQs About FTC v. Advocate Health Care Network

What court decided FTC v. Advocate Health Care Network?

The U.S. District Court for the Northern District of Illinois initially denied the FTC’s preliminary-injunction motion. The Seventh Circuit reversed that decision and ordered the transaction blocked while the FTC’s challenge proceeded.

Did Advocate and NorthShore complete their merger?

No. The parties abandoned the proposed merger in December 2016 after the Seventh Circuit ruled for the FTC.

What precedent is associated with the Advocate hospital merger case?

The principal precedent is FTC v. Advocate Health Care Network, 841 F.3d 460 (7th Cir. 2016). The decision addresses preliminary injunction standards and geographic market definition in hospital-merger litigation.

Why was the Chicago hospital market treated as local?

The court considered evidence that patients, physicians, and insurers do not view all hospitals across the Chicago metropolitan area as equivalent substitutes. Travel time, hospital capabilities, physician relationships, and network design constrained effective substitution.

What type of merger risk does Advocate create for hospital systems?

Advocate creates heightened risk for transactions involving direct hospital competitors with overlapping local facilities, high commercial-insurance shares, limited substitutes, and evidence that the parties compete directly in insurer negotiations.

References

Federal Trade Commission. (2015). FTC v. Advocate Health Care Network, No. 1:15-cv-11473 (N.D. Ill.). U.S. District Court for the Northern District of Illinois.

Federal Trade Commission. (2016). FTC v. Advocate Health Care Network, 841 F.3d 460 (7th Cir. 2016). U.S. Court of Appeals for the Seventh Circuit.

FTC v. Advocate Health Care Network, 841 F.3d 460 (7th Cir. 2016).

15 U.S.C. § 18.

15 U.S.C. § 53(b).